(3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl 4-methylbenzenesulfonate | 1609235-67-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 萘并吡喃类
• 英文名称: (3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl 4-methylbenzenesulfonate
• 英文别名: 3,4-dihydro-2H-benzo[h]chromen-2-ylmethyl 4-methylbenzenesulfonate
• CAS: 1609235-67-7
• 化学式: C₂₁H₂₀O₄S
• 分子量: 368.453
• InChiKey: LFSFLQNAQLFTJR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  61
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl 4-methylbenzenesulfonate 在 sodium azide 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.5h， 生成 N-((3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl)-3-methylbutanamide
  参考文献：
  名称：

  Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors

  摘要：

  A novel class of NF-kappa B inhibitors were designed and synthesized based on KL-1156 (6-hydroxy-7-methoxychroman-2-carboxylic acid phenyl amide) which is unambiguously considered to be a promising inhibitor for the translocation step of NF-kappa B. Especially in this study we focused on the modifying the chroman moiety of KL-1156 into four parts for exploring the SAR studies linked with physical properties of substituents resulted the development of novel 1a-k, 2a-f, 3a-d and 4a-d derivatives of 3,4-dihydro-2H-benzo[h] chromene. From the SAR studies we were very delightfully identified that several new N-aryl-3,4-dihydro-2H-benzo[h] chromene-2-carboxamide derivatives (1a-k) exhibited good inhibitory activity and anti-proliferative activity than parent lead compound KL-1156, among them 1i exhibited outstanding inhibitory effect on LPS-induced NF-kappa B transcriptional activity and anti-proliferative activity on NCI-H23 lung cancer cell lines than KL-1156. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.04.053
• 作为产物：
  描述：

  2-carbethoxy-3,4-dihydro-2H-naphtho[1,2-b]pyran 在 4-二甲氨基吡啶 、 lithium aluminium tetrahydride 、 三乙胺 、 potassium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 异丙醇 为溶剂， 反应 9.5h， 生成 (3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl 4-methylbenzenesulfonate
  参考文献：
  名称：

  Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors

  摘要：

  A novel class of NF-kappa B inhibitors were designed and synthesized based on KL-1156 (6-hydroxy-7-methoxychroman-2-carboxylic acid phenyl amide) which is unambiguously considered to be a promising inhibitor for the translocation step of NF-kappa B. Especially in this study we focused on the modifying the chroman moiety of KL-1156 into four parts for exploring the SAR studies linked with physical properties of substituents resulted the development of novel 1a-k, 2a-f, 3a-d and 4a-d derivatives of 3,4-dihydro-2H-benzo[h] chromene. From the SAR studies we were very delightfully identified that several new N-aryl-3,4-dihydro-2H-benzo[h] chromene-2-carboxamide derivatives (1a-k) exhibited good inhibitory activity and anti-proliferative activity than parent lead compound KL-1156, among them 1i exhibited outstanding inhibitory effect on LPS-induced NF-kappa B transcriptional activity and anti-proliferative activity on NCI-H23 lung cancer cell lines than KL-1156. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.04.053

文献信息

• Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
  申请人：Wyeth

  公开号：US20030100579A1

  公开（公告）日：2003-05-29

  Compounds of the formula 1 useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.

  该公式1的化合物可用于治疗抑郁症和其他疾病，如强迫症、恐慌症、广泛性焦虑障碍、社交焦虑障碍、性功能障碍、进食障碍、肥胖症、由乙醇或可卡因滥用引起的成瘾性障碍以及相关疾病。
• Process for stereoselective synthesis of 2-hydroxymethyl chromans
  申请人：Wyeth

  公开号：US20030105342A1

  公开（公告）日：2003-06-05

  A process for the stereoselective synthesis of 2-hydroxymethyl-chromans of formula (II) is provided 1 where R, R 1 , R 2 and R 3 are as defined herein. The compound of formula (II) is prepared using an optically active benzene compound of formula (I) 2 where R 0 is as defined herein. The 2-hydroxymethyl-chroman compounds of formula (II) are useful as intermediates for preparing a variety of medicinal agents.

  提供了一种对式选择性合成公式（II）的2-羟甲基-色基的过程，其中R、R1、R2和R3如此处所定义。使用公式（I）的光学活性苯化合物（其中R0如此处所定义）制备公式（II）的化合物。公式（II）的2-羟甲基-色基化合物可用作制备各种药物的中间体。
• US6667322B2
  申请人：——

  公开号：US6667322B2

  公开（公告）日：2003-12-23
• US6700001B2
  申请人：——

  公开号：US6700001B2

  公开（公告）日：2004-03-02